Home Cart Sign in  
Chemical Structure| 17318-31-9 Chemical Structure| 17318-31-9

Structure of SQ22536
CAS No.: 17318-31-9

Chemical Structure| 17318-31-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

SQ22536 is an effective inhibitor of adenylate cyclase (AC).

Synonyms: NSC 53339; 9-(tetrahydrofuran-2-yl)-9h-purin-6-amine; SQ 22,536. NSC 53339

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of SQ22536

CAS No. :17318-31-9
Formula : C9H11N5O
M.W : 205.22
SMILES Code : NC1=C2N=CN(C3OCCC3)C2=NC=N1
Synonyms :
NSC 53339; 9-(tetrahydrofuran-2-yl)-9h-purin-6-amine; SQ 22,536. NSC 53339
MDL No. :MFCD00210216
InChI Key :UKHMZCMKHPHFOT-UHFFFAOYSA-N
Pubchem ID :5270

Safety of SQ22536

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of SQ22536

GPCR

Isoform Comparison

Biological Activity

Target
  • AC

In Vitro:

Cell Line
Concentration Treated Time Description References
human platelets 100 μM 3 minutes To investigate the effect of SQ22536 on CBN-mediated inhibition of platelet aggregation, results showed that SQ22536 did not significantly reverse CBN-mediated inhibition of platelet aggregation. PMC7201758
Human Umbilical Vein Endothelial Cells (HUVECs) 200 μM 1 hour SQ22536, as an adenylate cyclase inhibitor, blocked the caffeine-induced AMPK phosphorylation, indicating that the cAMP/PKA signaling pathway acts as an upstream activator in caffeine-induced endothelial cell migration. PMC8632980

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.87mL

0.97mL

0.49mL

24.36mL

4.87mL

2.44mL

48.73mL

9.75mL

4.87mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories